Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Anti-Idiotypic
  • Arthritis, Rheumatoid
  • Peptides, Cyclic
  • Rheumatoid Factor

abstract

  • Although seronegative subjects with EIA have higher baseline DAS28 compared to seropositive subjects, they have a good response to treatment and are less likely to develop erosive disease during followup.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.3899/jrheum.140082

PubMed ID

  • 25274884

Additional Document Info

start page

  • 2361

end page

  • 9

volume

  • 41

number

  • 12